Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
Young Innovations, Inc. (YDNT)
Q3 2008 Earnings Call Transcript
October 23, 2008, 12:00 pm ET
Alfred Brennan – Chairman and CEO
Rick Kempe [ph] – Robert W. Baird
» Hansen Medical, Inc. Q3 2009 Earnings Call Transcript
» Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
Thank you Clara. Thank you very much for joining us this morning and good morning. For security laws’ purposes, certain information provided on this call may constitute forward-looking statements. Please refer to our most recent Annual Report on Form 10-K on an explanation of what constitutes a forward-looking statements and the related implications.
We appreciate you joining us this morning as we discuss the results of the company for the third quarter. It continued to be about execution and we began to see more effective focus in our selling and marketing area as we continued to strengthen on the organization we have built and the staff realignment emphasizing sales continued. We restructured our production planning process for our micro-applicators business. We brought the preventive product lines into focus with selective price increases during the quarter that we believe will help us be more effective throughout the rest of the year and into ’09 and our infection control product lines, we brought focus to our BIREX products with enhanced messaging and training of our staff as well as our channel. In the homecare area, we brought focus to our new products as we had completed a price increase last quarter as well as enhancing the number of new customers we acquired and a sales team in the homecare area met their goal in acquiring new customers during the third quarter enhancing results.
Our diagnostic product lines remain challenging, we continue to focus on sales effectiveness in a changing market. We continue to focus on converting our existing field population to digital sensors and we look forward to the introduction of an integrated digital product in the fourth and first quarter. We did see some slowdown in converting doctors at the end of the quarter similarly to what we saw after 09/11 as the economic uncertainty did provide some concern to a number of our impending customers. The overall benefits of consolidation were brought into focus during the quarter as we saw strengthening of performance by the staff additions. In the fourth quarter we plan to complete the final facility consolidation which will bring to seven in the last 17, 18 months that we have completed. We have a number of new product introductions planned in the fourth quarter and first quarter that we are excited about and appear on track and we enter this period of economic uncertainty more focused and overall stronger than we were two years ago.
As part of the vision for the company also at the end of the quarter George Richmond’s transition to Vice Chairman except recommending an age restriction for Chairman of Committees of 75 for our board, he continues to serve on our board and contribute in his desire (inaudible) he has formed looking forward to ever-increasing opportunities in healthcare. He built the solid foundation of innovation and integrity during his service and we are grateful for his steady hand and his experience and insight and commitment to oral healthcare as he continues to serve the company going forward.
At this point, I would be glad to entertain any questions about the quarter or opportunities we have in the future.
(Operator instructions) Your next question comes from the line of Rick Kempe [ph] with Robert W. Baird, your line is open sir.
Rick Kempe – Robert W. Baird
Hi, good morning everyone.
Good morning Rick.
Rick Kempe – Robert W. Baird
Hi just a couple of questions firstly on the equipment side, I was wondering if you could help out with what percent of the business that is, I think we used to think of it as trending in the 15% range but just as we look forward from here, whereabouts is it right now?
It’s been in that range historically, that is not something that we have broken out but if you look at the historical numbers that is not inconsistent. Clearly in this quarter we are a little below trend line and most of the cost for us to drop out of our 4% to 6% historical internal growth rate which we have talked about consistently through the years is due to the panoramic performance.
Rick Kempe – Robert W. Baird
Then is your new system launches (inaudible) over the Q4 and Q1, when do you think we could start to see some benefit from that or do you think that this quarter’s shortfall was more because of the comp and because of the economy?
I think it was three things really. One, it was continued struggles we have had internally with sales execution which I think we addressed during the month of September. We clearly saw some issues in July and August. Quite frankly people did not make their specific targets and we went in with different sales managers at the end of the quarter and we saw good results in September. We also saw and we had done a number of focus groups which Denis [ph] tends to manage their practices with cash while we had a number of properly qualified accounts with credit, we are either financing with cash or financing with credit. We did see significant increase in the delays, people requesting a delay as they waited out to see how things were going to go for the rest of the year. I think credit tightening did affect us to a degree. We did have a couple of comparable areas in some government sales and some international sales that have been there prior year, that were not there this year but overall it is a small business those things come and go and our focus right now is on selling effectiveness and really the launch of the new product which we think should affect our fourth quarter and first quarter results and appears to be in reasonably good shape. But to be clear and certain, the business is still in a condition that needs continued care and attention and focus and we don’t think we are totally out of the woods there yet.